Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co (STAA)

Broadwood Partners, along with related entities and individuals, reported the acquisition of additional shares of STAAR Surgical Co common stock between February 27, 2025, and March 3, 2025, increasing their holdings.

Summary

• Broadwood Partners, L.P. has increased its holdings in STAAR Surgical Co (STAA) through a series of purchases.
• The transactions occurred between February 27, 2025, and March 3, 2025.
• The purchases were made at varying prices, ranging from $16.00 to $18.195 per share.
• The total number of shares beneficially owned by Broadwood Partners after these transactions is 11,953,198.
• Neal C. Bradsher, as President of Broadwood Capital, Inc. (the General Partner of Broadwood Partners), and individually, also reported these transactions.
• Neal C. Bradsher directly owns 25,900 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed as a positive sign, but the filing itself is a routine regulatory disclosure.

Positives

• Increased investment by a major shareholder could be interpreted as a positive signal about the company's prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the overall context and motivations behind the purchases.

Stakeholder Impact

• The increased stake by Broadwood Partners could reassure shareholders about the company's direction.

Key Dates